We report here a de novo missense variant in HIST1H4J resulting in a complex syndrome combining growth delay, microcephaly and intellectual disability. Trio whole exome sequencing (WES) revealed that the proband was heterozygous for a de novo c.274 A > G p.(K91E) variant in HIST1H4J, a gene not yet associated with human disease. The patient presented with profound intellectual disability, microcephaly, and dysmorphic facial features. Functional consequences of the identified de novo missense variant were evaluated in zebrafish embryos, where they affected general development, especially resulting in defective head organs and reduced body axis length. Our results show that the monoallelic p.K91E substitution on HIST1H4J underlies a human syndrome that is genetically and phenotypically akin to the HIST1H4C-associated neurodevelopmental disorder resulting from p.K91A and p.K91Q substitions in HIST1H4C. The highly overlapping patient phenotypes highlight functional similarities between HIST1H4J and HIST1H4C perturbations, establishing the singular importance of K91 across histone H4 genes for vertebrate development.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171094PMC
http://dx.doi.org/10.1038/s41431-019-0552-9DOI Listing

Publication Analysis

Top Keywords

hist1h4j gene
8
hist1h4c-associated neurodevelopmental
8
neurodevelopmental disorder
8
novo missense
8
missense variant
8
variant hist1h4j
8
intellectual disability
8
hist1h4j
5
novo
4
novo variant
4

Similar Publications

[Effect of CXCR4 on the Treatment Response and Prognosis of Carfilzomib in Multiple Myeloma].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

April 2022

The Affiliated Huai'an No.1 People's Hospital of Nanjing Medical University, The Huai'an Clinical College of Xuzhou Medical University, Key Laboratory of Hematology of Nanjing Medical University, Huai'an 223300, Jiangsu Province, China,E-mail:

Article Synopsis
  • The study investigates how the CXCR4 gene influences the effectiveness of Carfilzomib (CFZ) treatment in patients with multiple myeloma (MM).
  • Researchers analyzed data from CFZ-resistant and parental MM cell lines to identify key genes related to CFZ resistance using microarray data and protein-protein interaction networks.
  • Findings reveal that high levels of CXCR4 expression are linked to increased relapse rates and decreased overall survival in MM patients, suggesting CXCR4 could be a target for improving treatment responses in resistant cases.
View Article and Find Full Text PDF

To identify the related genes of low-dose ionizing radiation on basis of association analysis of transcriptome and proteome data, and provide new clues for the molecular mechanism of low-dose radiation (LDR) effect. In March 2018, healthy human peripheral blood was used as materials for transcriptome sequencing and proteome analysis after exposure to radiation at 150 mGy (treatment group) and no radiation (control group) , with three samples in each group. The total RNA and protein were extracted and then correlation analysis of transcriptomic and proteomic were performed to determine LDR effect-related genes, and after that, the biological process and molecular function were analyzed.

View Article and Find Full Text PDF

We report here a de novo missense variant in HIST1H4J resulting in a complex syndrome combining growth delay, microcephaly and intellectual disability. Trio whole exome sequencing (WES) revealed that the proband was heterozygous for a de novo c.274 A > G p.

View Article and Find Full Text PDF

Lung epithelial cells constitute the first defense line of host against the inhaled Aspergillus fumigatus; however, the transcriptional response of human alveolar type II epithelial cells was still unclear. Here we used RNA-Seq technology to assess the transcriptome profiles of A549 cells following direct interaction with conidia of A. fumigatus.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!